International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
26(1), P. 212 - 212
Published: Dec. 30, 2024
Ischemia/reperfusion
(IR)
injury
is
a
complex
pathophysiological
process
in
which
the
restoration
of
blood
flow
to
ischemic
tissue
paradoxically
exacerbates
damage
and
death
[...].
Brain Sciences,
Journal Year:
2025,
Volume and Issue:
15(3), P. 248 - 248
Published: Feb. 26, 2025
Multiple
sclerosis
(MS)
is
an
autoimmune
disease
that
damages
the
myelin
sheath
around
central
nervous
system
axons,
leading
to
neurological
dysfunction.
Although
initial
damage
driven
by
inflammation,
hypoxia
has
been
reported
in
several
brain
regions
of
MS
patients,
but
significance
this
for
prognosis
and
treatment
remains
unclear.
Neuroinflammation
can
induce
hypoxia,
exacerbate
neuroinflammation,
forming
a
vicious
cycle.
Within
lesions,
demyelination
often
followed
remyelination,
which
may
restore
function.
However,
demyelinated
axons
are
vulnerable
damage,
leads
accumulation
permanent
dysfunction
typical
MS,
with
vulnerability
heightened
during
hypoxia.
Clinically
approved
therapies
immunomodulatory,
reduce
relapse
frequency/severity,
there
lack
pro-regenerative
example
promoting
remyelination.
All
tissues
have
protective
responses
be
relevant
especially
remyelinating
episodes.
When
oxygen
levels
reduced
brain,
constitutively
expressed
hypoxia-inducible
factors
(HIF)
stabilised,
upregulating
hundreds
genes,
including
neuroprotective
factors.
Furthermore,
astrocytes
upregulate
heparin-binding
epidermal
growth
factor
(EGF)-like
(HB-EGF)
early
stage
MS.
HB-EGF
promotes
mechanisms
induces
oligodendrocyte
neuron
differentiation
survival.
This
review
article
outlines
neuroinflammation
cycle
pathology
identifies
potential
therapeutic
targets
limit
neurodegeneration
and/or
promote
regeneration.
Both
HIF
signalling
pathways
endogenous
protection
CNS,
neuroprotection
remyelination
directly,
also
indirectly
modulating
immune
response
Promoting
such
could
effective
therapy
patients.
Advanced Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 2, 2025
Chronic
noncommunicable
diseases
(NCDS)
are
often
characterized
by
gradual
onset
and
slow
progression,
but
the
difficulty
in
early
prediction
remains
a
substantial
health
challenge
worldwide.
This
study
aims
to
explore
interconnectedness
of
disease
occurrence
through
multi-omics
studies
validate
it
large-scale
electronic
records.
In
response,
research
examined
data
from
160
sub-healthy
individuals
at
high
altitude
then
deep
learning
model
called
Omicsformer
is
developed
for
detailed
analysis
classification
routine
blood
samples.
adeptly
identified
potential
risks
nine
including
cancer,
cardiovascular
conditions,
psychiatric
conditions.
Analysis
risk
trajectories
20
years
large
clinical
patients
confirmed
validity
group
preclinical
assessment,
revealing
trends
increased
time
onset.
Additionally,
straightforward
NCDs
system
developed,
utilizing
basic
test
results.
work
highlights
role
multiomics
chronic
risk,
development
validation
predictive
models
based
on
results
can
help
advance
personalized
medicine
reduce
cost
screening
community.
Journal of Neuroinflammation,
Journal Year:
2025,
Volume and Issue:
22(1)
Published: April 21, 2025
Abstract
Global
ischemic
brain
injury
occurs
after
cardiac
arrest
or
prolonged
hypotensive
episodes
following
surgery
trauma.
It
causes
significant
neurological
deficits
even
successful
re-establishment
of
blood
flow.
is
the
primary
cause
death
in
68%
inpatient
and
23%
out-of-hospital
cases,
but
there
are
currently
no
treatments.
Endothelial
activation
dysfunction
impairing
small
vessel
flow
damage.
Purinergic
signaling
an
endogenous
molecular
pathway,
where
CD39
CD73
catabolize
extracellular
adenosine
triphosphate
(eATP)
to
adenosine.
After
ischemia,
eATP
released,
triggering
thrombosis
inflammation.
In
contrast,
anti-thrombotic,
protects
against
oxidative
stress,
suppresses
immune
response.
Our
group
developed
a
bifunctional
compound
–
anti-VCAM-CD39
that
targets
dysregulated
endothelium
promotes
generation
at
infarct
site,
localising
antithrombotic
anti-inflammatory
effects
CD39.
We
investigated
whether
could
improve
outcome
murine
model
global
ischaemia
caused
by
dual
carotid
artery
ligation
(DCAL).
Test
drugs
controls
were
given
3
h
30
min
ischaemia.
Assessments
24
included
function,
volume,
perfusion,
albumin
extravasation
assess
blood-brain
barrier
(BBB)
permeability.
showed
was
overall
improvement
deficit
anti-VCAM-CD39-treated
mice
DCAL.
MRI
revealed
these
had
significantly
smaller
infarcts
reduced
apoptotic
activity
on
side
permanent
occlusion,
compared
saline
treated
mice.
There
DCAL,
suggesting
conferred
neuroprotection
through
preservation
BBB
vitro
findings
confirmed
anti-VCAM-CD39-mediated
production
protected
hypoxia-induced
endothelial
cell
death.
novel
therapeutic
can
promote
neuroprotection,
reduce
tissue
damage
inflammation
hypoxic
These
suggest
be
new
avenue
therapy
potentially
used
other
cerebrovascular
diseases
constant
underlying
pathology.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(19), P. 10484 - 10484
Published: Sept. 29, 2024
The
human
brain
is
highly
dependent
on
oxygen,
utilizing
approximately
20%
of
the
body’s
oxygen
at
rest.
Oxygen
deprivation
to
can
lead
loss
consciousness
within
seconds
and
death
minutes.
Recent
studies
have
identified
regions
with
spontaneous
episodic
hypoxia,
referred
as
“hypoxic
pockets”.
Hypoxia
also
result
from
impaired
blood
flow
due
conditions
such
heart
disease,
clots,
stroke,
or
hemorrhage,
well
reduced
intake
excessive
consumption
caused
by
factors
like
low
ambient
pulmonary
diseases,
infections,
inflammation,
cancer.
Severe
hypoxia
in
manifest
symptoms
similar
Parkinson’s
disease
(PD),
including
cerebral
edema,
mood
disturbances,
cognitive
impairments.
Additionally,
development
PD
appears
be
closely
associated
hypoxic
pathways.
This
review
seeks
investigate
molecular
interactions
between
PD,
emphasizing
pathological
role
pathways
exploring
their
potential
therapeutic
targets.
Frontiers in Bioscience-Landmark,
Journal Year:
2024,
Volume and Issue:
29(12)
Published: Dec. 20, 2024
As
one
of
the
most
common
solid
pediatric
cancers,
Neuroblastoma
(NBL)
accounts
for
15%
all
cancer-related
mortalities
in
infants
with
increasing
incidence
around
world.
Despite
current
therapeutic
approaches
NBL
(radiotherapies,
surgeries,
and
chemotherapies),
these
could
not
be
beneficial
patients
due
to
their
low
effectiveness,
some
severe
side
effects.
These
challenges
lead
basic
medical
scientists
clinical
specialists
toward
an
optimal
interventions
management
NBL.
Regardingly,
taking
molecular
cellular
immunopathophysiology
involved
hypoxic
microenvironment
into
account,
it
can
practically
a
contributing
approach
development
"molecular
medicine"
treatment
Interestingly,
pivotal
roles
"herbal
have
been
extensively
interrogated
treating
NBL,
functionally
being
served
as
anti-cancer
agent
via
inducing
wide
range
signaling,
like
apoptosis,
cell
cycle
arrest,
inhibiting
angiogenesis.
Hence,
this
review
study,
authors
aim
summarize
anti-tumor
effects
medicinal
plants
phytoconstituents
through
immunopathophysiological
mechanisms
In
addition,
they
try
open
promising
windows
immune
gene-based
therapies
"precision
advantages
herbal
medicine.
An
interdisciplinary
collaboration
among
translation
medicine
specialists,
immunobiologists,
neuro-oncologists
is
highly
recommended.